The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.

Saved in:
Bibliographic Details
Title: The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.
Authors: Johnston SC; Dell Medical School, University of Texas at Austin, Austin, TX, USA., Amarenco P; Department of Neurology and Stroke Centre, Bichat Hospital, Paris Diderot, Paris, France., Denison H; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Evans SR; Biostatistics Center, George Washington University, Washington DC, MD, USA., Himmelmann A; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., James S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Knutsson M; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Ladenvall P; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Molina CA; Stroke Unit, Hospital Vall d'Hebron, Barcelona, Spain., Wang Y; Department of Neurology, Beijing Tiantan Hospital, Beijing, China.
Corporate Authors: THALES Investigators
Source: International journal of stroke : official journal of the International Stroke Society [Int J Stroke] 2019 Oct; Vol. 14 (7), pp. 745-751. Date of Electronic Publication: 2019 Feb 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101274068 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4949 (Electronic) Linking ISSN: 17474930 NLM ISO Abbreviation: Int J Stroke Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1747-4949
DOI:10.1177/1747493019830307